Europe — EMA
Xgeva (Denosumab)
Xgeva (denosumab) is a prescription medication used to help prevent bone complications in patients with bone metastases from solid tumors. It belongs to a class
Request sourcing
What is Denosumab?
Xgeva (denosumab) is a prescription medication used to help prevent bone complications in patients with bone metastases from solid tumors. It belongs to a class of drugs known as RANK ligand inhibitors. Xgeva is administered as a subcutaneous injection.
What is Denosumab used for?
Xgeva is commonly used to reduce the risk of bone fractures, spinal cord compression, and other bone-related complications in patients with bone metastases from solid tumors. It is also used to treat giant cell tumor of bone in adults and skeletally mature adolescents. Patients often ask, 'what is Xgeva used for' to understand its role in managing bone health during cancer treatment.
What are the side effects of Denosumab?
Xgeva works by slowing bone breakdown and helping to maintain stronger bones. Many patients experience improved bone stability and reduced pain associated with bone metastases. The medication supports overall skeletal health during cancer therapy.
What precautions apply to Denosumab?
Xgeva should be used under medical supervision, as it may cause low calcium levels in the blood. Patients with a history of kidney problems or those taking other bone medications should discuss risks with their healthcare provider. Regular monitoring may be required during treatment.
What does Denosumab interact with?
Xgeva may interact with other medications that affect bone metabolism, such as bisphosphonates or corticosteroids. Patients should inform their doctor about all prescriptions, over-the-counter drugs, and supplements. Alcohol and tobacco use may also influence bone health during treatment.
